1. Home
  2. Labeler Index
  3. Azurity Pharmaceuticals, Inc.
  4. 24338-017
  5. NDC Package Code: 24338-017-01 Brynovin

NDC Package 24338-017-01 Brynovin

Sitagliptin Hydrochloride Oral Solution Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
24338-017-01
Package Description:
1 BOTTLE in 1 CARTON / 120 mL in 1 BOTTLE
Product Code:
24338-017
Proprietary Name:
Brynovin
Non-Proprietary Name:
Sitagliptin Hydrochloride Oral
Substance Name:
Sitagliptin
Usage Information:
BRYNOVIN is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.Limitations of UseBRYNOVIN is not recommended in patients with type 1 diabetes.BRYNOVIN has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using BRYNOVIN. [see Warnings and Precautions (5.1)].
11-Digit NDC Billing Format:
24338001701
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Azurity Pharmaceuticals, Inc.
Dosage Form:
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
SITAGLIPTIN 25 mg/mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
NDA219122
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
04-01-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 24338-017-01?

The NDC Packaged Code 24338-017-01 is assigned to a package of 1 bottle in 1 carton / 120 ml in 1 bottle of Brynovin, a human prescription drug labeled by Azurity Pharmaceuticals, Inc.. The product's dosage form is solution and is administered via oral form.

Is NDC 24338-017 included in the NDC Directory?

Yes, Brynovin with product code 24338-017 is active and included in the NDC Directory. The product was first marketed by Azurity Pharmaceuticals, Inc. on April 01, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 24338-017-01?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 24338-017-01?

The 11-digit format is 24338001701. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-224338-017-015-4-224338-0017-01